Healthcare and Life Science
Clinical insights: Respiratory care digital innovation opportunities
Co-authored by Dr Bipin Patel, CEO, electronRx, Cambridge, UK and Dr Hiromichi Yamaguchi, Yamaguchi Respiratory Clinic and Dermatology, Tokyo, Japan. ...
From complexity to clarity: analytics in cell and gene therapy
Cell and gene therapies (CGTs) have redefined the treatment landscape, but their development and manufacturing remain uniquely challenging. They involve variable starting materials and complex, small-scale processes. As the field pushes for faster development, scalable manufacturing and...
NPZ Technology and CCV to showcase cross-border innovation at Cambridge Tech Week 2025
As Innovation Zone Sponsors at Cambridge Tech Week 2025, NPZ Technology Ltd and Cambridge Collaborative Ventures Ltd (CCV) will host an exhibition zone in Innovation Alley, featuring five cross-border innovation companies in digital health, VR, robotics, and AI. ...
Antibodies.com expands UK headquarters with new 5x larger facilities in Cambridge to accommodate rapid growth
Cambridge, UK, 04 August 2025: Antibodies.com, a trusted provider of high-quality biological reagents for life science researchers, today announced the expansion of its UK headquarters with a move to Cambridge Technopark to accommodate the Company’s rapid growth. The new 5000 sq. ...
Team Consulting and inclusive surgical devices at Royal College of Surgeons of England event
Team Consulting are attending the Women at the Cutting Edge event hosted by the Royal College of Surgeons of England, in partnership with the RCS England I-Hub and Women in Surgery (WinS) group, on Friday 17th October 2025 at the Birmingham Repertory Theatre. Team's Senior FEI Strategy...
Radiotherapy and surgical ablation technologies for cancer treatment
Radiotherapy, or radiation ablation, has evolved significantly since its inception. Ongoing technological advancements have the potential to position radiotherapy as a first-line “surgical” treatment for solid tumours by enhancing its precision and efficacy. Further advancements in real...
How surrogate models enhance medical device optimisation
Design optimisation is a fundamental step in developing innovative and efficient medical devices. Before committing to manufacturing prototypes, simulations and models are developed to indicate the expected performance of the medical device design. They offer great precision however,...
Preventing patient hospitalisation through better stratification and timely intervention
In the realm of healthcare, patient hospitalisation can often be avoided through timely intervention and appropriate medication management. One powerful strategy to achieve this is patient stratification—classifying patients into different groups based on their vulnerability to hos...
Centauri Therapeutics receives an additional $5.1M from CARB-X to progress ABX-01 lead compound to first in human clinical trials
CARB-X provides an additional $5.1M to complete the non-clinical safety and efficacy studies with ABX-01 lead candidateCentauri plans the progression of lead candidate, an immunotherapy based broad-spectrum antimicrobial, to a first in human clinical study in early 2026CARB-X’s addition...
Exonate plans ‘CLEAR-DE’ Phase IIb clinical trial of lead candidate EXN407 for diabetic eye disease
EXN407 is the first topical SRPK1 inhibitor to demonstrate safety and efficacy as a monotherapy for non-proliferative diabetic retinopathy (NPDR) and diabetic macular oedemaPhase IIb trial to investigate efficacy in NPDR patients to commence in Q1 2026Cambridge, UK, 29 July 2025: E...